Paul Radford

Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor–associated periodic syndrome indicates misfolding consistent with abnormal function

Susana L. Rebelo, Susan Bainbridge, Mohammad R. Amel‐Kashipaz et al. · Arthritis & Rheumatism · 2006 · 114 citations

Life Sciences, Cell Biology, Molecular Biology +12

Role of interleukin‐6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin‐6 receptor monoclonal antibody tocilizumab

Prashantha Vaitla, Paul Radford, Patrick J. Tighe et al. · Arthritis & Rheumatism · 2011 · 107 citations

Life Sciences, Immunology, Pharmacology +16

Mutant forms of tumour necrosis factor receptor I that occur in TNF‐receptor‐associated periodic syndrome retain signalling functions but show abnormal behaviour

Ian Todd, Paul Radford, Kelly‐Ann Draper‐Morgan et al. · Immunology · 2004 · 94 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: Differences between cell types

Mary L. Huggins, Paul Radford, Richard S. McIntosh et al. · Arthritis & Rheumatism · 2004 · 77 citations

Life Sciences, Cell Biology, Immunology +12

Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus

Susan Trigwell, Paul Radford, Sean Page et al. · Clinical & Experimental Immunology · 2001 · 72 citations · Full text

Life Sciences, Endocrinology, Immunology +15